Download Sample
Add to CartProtein Sequencing Market
By Product and Service;
Sample Preparation Products & Services, Protein Sequencing Products-[Reagents & Consumables, Instruments (Mass Spectrometry Instruments and Edman Degradation Sequencers) and Analysis Products & Software], Protein Sequencing Services and OthersBy Technology;
Edman Degradation and Mass SpectrometryBy Application;
Biotherapeutics, Genetic Engineering and OthersBy End User;
Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Protein Sequencing Market Overview
Protein Sequencing Market (USD Million)
Protein Sequencing Market was valued at USD 1,740.35 million in the year 2024. The size of this market is expected to increase to USD 2,247.37 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 3.7%.
Protein Sequencing Market
*Market size in USD million
CAGR 3.7 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 3.7 % |
| Market Size (2024) | USD 1,740.35 Million |
| Market Size (2031) | USD 2,247.37 Million |
| Market Concentration | High |
| Report Pages | 331 |
Major Players
- Thermo Fisher Scientific, Inc.
- Agilent Technologies, Inc.
- Bruker Corporation
- Waters Corporation
- Shimadzu Corporation
- PerkinElmer, Inc.
- Bio-Rad Laboratories, Inc.
- GE Healthcare (a subsidiary of General Electric Company)
- Danaher Corporation
- Sartorius AG
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Protein Sequencing Market
Fragmented - Highly competitive market without dominant players
The protein sequencing market is expanding rapidly due to the increasing relevance of proteomics in personalized medicine and disease research. Protein sequencing, which involves determining the amino acid order in a protein, is central to understanding its structure and function. With proteins playing key roles in nearly 60% of disease-related biological processes, the demand for high-throughput and precise sequencing tools is escalating to support advanced research and treatment innovation.
Technological Progress Transforming Protein Analysis
The market is benefiting significantly from advancements in mass spectrometry and next-generation sequencing technologies. These innovations enable rapid, highly sensitive analysis of protein structures, with more than 55% of proteomics studies now incorporating mass spectrometry for detailed profiling. The integration of AI-based bioinformatics tools is also growing, contributing to roughly 40% of data analysis workflows, which enhances the depth and speed of biological insight.
Strategic Role in Drug Development and Therapeutic Quality
Protein sequencing plays a pivotal role in pharmaceutical R&D, especially in the development and validation of biologics such as monoclonal antibodies. Approximately 65% of biologic drug assessments now involve sequencing to ensure consistency, safety, and potency. Additionally, protein sequencing supports the evaluation of drug-protein interactions and immunogenicity, helping researchers design safer and more effective treatment options.
Accelerating Growth Through Targeted Therapeutic Innovation
The shift toward precision medicine is fueling the adoption of protein sequencing in clinical and research environments. This trend is especially pronounced in oncology, where over 50% of research programs use protein sequencing to identify biomarkers and develop targeted therapies. With continuous improvements in technology and growing applications in life sciences, the protein sequencing market is set to experience sustained growth.
Protein Sequencing Market Key Takeaways
-
The growing focus on proteomics and target-based drug discovery is accelerating demand for advanced protein sequencing technologies across the biopharmaceutical sector.
-
North America maintains market leadership due to high R&D investment and strong infrastructure, while Asia-Pacific is emerging as the fastest-growing region driven by expanding biotech ecosystems.
-
High adoption of reagents and consumables—accounting for the largest revenue share—reflects the rising need for accuracy and throughput in amino acid sequencing workflows.
-
The increasing role of bioinformatics software and AI/ML integration is transforming protein analysis, enhancing data interpretation and reducing turnaround times.
-
Advances in next-generation sequencing (NGS), mass spectrometry, and nanopore technologies are expanding the application range of protein sequencing in personalized medicine and biomarker discovery.
-
High instrument costs and the requirement for specialized expertise remain key barriers to widespread adoption, particularly in developing economies.
-
Pharmaceutical companies and contract research organizations (CROs) are increasingly outsourcing sequencing services to enhance biologics characterization and quality control efficiency.
Protein Sequencing Market Recent Developments
-
In July 2024, the protein sequencing market saw a notable increase, growing from USD 1.55 billion in 2023 to USD 1.7 billion in 2024. This growth is largely fueled by expanding applications in diagnostics, rising demand from the pharmaceutical sector, and ongoing advancements in both genetic and environmental research. These factors are collectively driving broader adoption of protein sequencing technologies across research and clinical domains.
-
In February 2024, Quantum-Si launched its Protein Sequencing Kit V2, designed to deliver improved performance while significantly reducing sequencing costs. This upgraded kit is especially advantageous for use in proteomics research and biomarker discovery, offering researchers a more efficient and accessible tool for advanced protein analysis.
Protein Sequencing Market Segment Analysis
In this report, the Protein Sequencing Market has been segmented by Product & Service, Technology, Application, End User, and Geography.
Protein Sequencing Market Segmentation by Product & Service
The Protein Sequencing Market by Product & Service is classified into Sample Preparation Products & Services, Protein Sequencing Products (Reagents & Consumables, Instruments, and Analysis Products & Software), Protein Sequencing Services, and Others. Each of these components plays a vital role in the overall sequencing workflow, driving innovation in proteomics research, drug discovery, and biopharmaceutical development.
Sample Preparation Products & Services
Sample Preparation Products & Services are critical for obtaining high-quality protein samples suitable for sequencing analysis. This segment includes enzymatic digestion kits, purification systems, and concentration tools that enhance sensitivity and reproducibility. Increasing R&D investments and the demand for automated sample processing platforms are driving technological advancements in this area.
Protein Sequencing Products
Protein Sequencing Products comprise the essential reagents, consumables, and instrumentation required for accurate protein analysis. The segment benefits from the adoption of advanced mass spectrometry technologies and integration with bioinformatics platforms for data analysis and interpretation.
Reagents & Consumables
This sub-segment includes chemical reagents, buffers, and labeling kits used in protein extraction and sequencing workflows. Growing demand for high-throughput sequencing protocols and precision in peptide mapping supports steady growth.
Instruments (Mass Spectrometry Instruments and Edman Degradation Sequencers)
Mass Spectrometry Instruments dominate the market with their ability to provide high-resolution and accurate mass measurements. Meanwhile, Edman Degradation Sequencers continue to serve as essential tools for N-terminal protein sequencing in niche applications.
Analysis Products & Software
Analysis Products & Software facilitate data processing, protein identification, and structural interpretation. The integration of AI and machine learning algorithms is enhancing accuracy and enabling predictive proteomics capabilities.
Protein Sequencing Services
Protein Sequencing Services cater to organizations lacking in-house capabilities, offering customized analysis, peptide mapping, and de novo sequencing. These services are increasingly outsourced to specialized providers to reduce operational costs and improve turnaround times. Partnerships between academic institutions and biotech firms are further stimulating market expansion.
Others
The Others segment covers ancillary tools and services that support workflow optimization, quality control, and bioinformatics integration. Demand for interoperable systems and cloud-based data management solutions continues to grow in this category.
Protein Sequencing Market Segmentation by Technology
The Technology segmentation includes Edman Degradation and Mass Spectrometry. These complementary methods serve distinct analytical requirements, ranging from direct amino acid sequencing to complex peptide identification in large-scale proteomics studies.
Edman Degradation
Edman Degradation is one of the earliest and most reliable techniques for determining the N-terminal amino acid sequence of proteins. Though less prevalent today, it remains valuable for small peptides and confirmatory sequencing. Continuous advancements in microfluidic platforms and automation have improved its efficiency and precision.
Mass Spectrometry
Mass Spectrometry dominates modern protein sequencing due to its high sensitivity, accuracy, and scalability. It enables comprehensive analysis of post-translational modifications and protein-protein interactions. The integration of liquid chromatography (LC-MS/MS) and bioinformatics algorithms enhances identification throughput in pharmaceutical and clinical proteomics.
Protein Sequencing Market Segmentation by Application
The Application segmentation includes Biotherapeutics, Genetic Engineering, and Others. Each application area leverages protein sequencing for biomarker discovery, molecular characterization, and therapeutic design.
Biotherapeutics
Biotherapeutics represents the largest application area, where sequencing ensures structural validation, purity testing, and biosimilarity assessments for drug candidates. Regulatory requirements for amino acid sequence verification are propelling consistent demand from biopharmaceutical manufacturers.
Genetic Engineering
Genetic Engineering applications involve mapping protein expression patterns to optimize gene editing and recombinant protein production. Sequencing aids in validating constructs for CRISPR-based gene therapies and synthetic biology projects.
Others
The Others segment includes proteomic studies in academic and clinical research, environmental monitoring, and forensic applications. The adoption of omics-based multi-disciplinary research continues to expand sequencing usage beyond traditional biopharma domains.
Protein Sequencing Market Segmentation by End User
The End User segmentation comprises Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, and Others. Each segment contributes to expanding protein sequencing adoption based on its research objectives and resource capacity.
Academic Institutes & Research Centers
Academic Institutes & Research Centers remain crucial users of sequencing technologies for fundamental proteomics research and discovery-driven science. These institutions are driving innovations in bioinformatics tools, hybrid analytical workflows, and collaborative proteome mapping projects.
Pharmaceutical & Biotechnology Companies
Pharmaceutical & Biotechnology Companies lead in adopting sequencing technologies for drug development, biomarker identification, and therapeutic protein validation. Integration of sequencing with quality assurance and regulatory workflows accelerates new product development cycles.
Others
The Others category includes contract research organizations (CROs), diagnostic laboratories, and forensic institutes. These entities contribute significantly to the outsourcing trend in analytical testing and molecular profiling.
Protein Sequencing Market Segmentation by Geography
In this report, the Protein Sequencing Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
North America
North America dominates the market owing to strong investments in proteomics R&D, established biotechnology industries, and advanced healthcare infrastructure. The U.S. leads due to extensive adoption of mass spectrometry-based platforms and presence of major sequencing service providers.
Europe
Europe maintains significant market share driven by academic research initiatives and government-backed proteomics programs. The region’s focus on precision medicine and biopharmaceutical innovation fosters steady growth in sequencing adoption.
Asia Pacific
Asia Pacific is the fastest-growing region, supported by increasing investments in life sciences infrastructure and expansion of biotech startups in countries such as China, Japan, and India. Rising emphasis on personalized medicine and large-scale genomic research accelerates market expansion.
Middle East and Africa
The Middle East and Africa region is emerging with growing adoption of clinical proteomics and pharmaceutical research. Investments in healthcare modernization and academic collaborations are promoting awareness and accessibility of sequencing technologies.
Latin America
Latin America shows steady progress, led by Brazil and Mexico, where academic research and biotechnology development are expanding. Increasing partnerships with global firms and government-funded life sciences initiatives drive regional growth.
Protein Sequencing Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Protein Sequencing Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers
- Advancements in Proteomics Research
- Growing Demand for Personalized Medicine
-
Expanding Applications in Drug Discovery - The growing range of applications in drug discovery is a key factor driving the expansion of the protein sequencing market. As pharmaceutical and biotech companies aim to create more effective and targeted treatments, protein sequencing has become an essential part of molecular-level research. By revealing the amino acid sequence of proteins, this technology provides deep insights into protein function, structure, and interactions, enabling researchers to pinpoint potential drug targets more efficiently.
One of the most valuable uses of protein sequencing in drug development is the discovery and validation of biomarkers. These biomarkers are crucial for identifying disease states, evaluating drug efficacy, and guiding clinical decision-making. High-resolution sequencing techniques offer a detailed understanding of post-translational modifications, protein folding, and structural variants, all of which are critical for designing therapeutics with high specificity and minimal side effects. This capability is streamlining drug development pipelines by making the process faster and more accurate.
Protein sequencing also plays a central role in the advancement of biologic drugs, including monoclonal antibodies, enzyme therapies, and vaccines. These complex therapeutics require precise characterization to ensure stability, purity, and consistency throughout the manufacturing process. In the case of biosimilars, protein sequencing is essential to confirm structural and functional similarity to original biologics. As the demand for biologics continues to grow, so does the need for robust protein sequencing technologies.
Restraints
- High Costs of Sequencing Technologies
- Complex Data Analysis
-
Regulatory Compliance Challenges - Significant barrier to the expansion of the protein sequencing market. As protein sequencing technologies gain more clinical and pharmaceutical applications, they are subject to strict oversight from regulatory bodies like the U.S. FDA, European Medicines Agency (EMA), and others. These agencies require high standards of validation, reproducibility, and accuracy, particularly when sequencing data is used for diagnostics or drug development. Navigating these complex regulatory pathways can be time-consuming and costly for manufacturers.
Companies are required to comply with detailed protocols including Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP), while maintaining exhaustive documentation and undergoing regular audits. This is especially critical for sequencing platforms used in clinical settings or biologics production. For smaller firms and startups, meeting these requirements can strain limited resources, often resulting in delayed launches and limited ability to compete in regulated markets.
The lack of uniform global regulatory standards adds another layer of complexity. Technologies approved in one region may face additional validation demands in others, increasing time-to-market and operational redundancy. This fragmented landscape slows international expansion and limits the broader adoption of protein sequencing tools, particularly in countries with emerging regulatory frameworks or limited infrastructure for biotechnology approvals.
Opportunities
- Innovation in next-generation sequencing techniques
- Expansion into clinical diagnostics and biomarkers
- Growing collaborations in pharmaceutical research
-
Emerging markets adopting protein analysis tools - Opening new growth avenues for the protein sequencing market as these regions increase their adoption of advanced protein analysis tools. Nations acrossAsia-Pacific, Latin America, the Middle East, and Africa are investing heavily in biotechnology infrastructure through government initiatives, international collaborations, and public-private partnerships. As healthcare systems and research capabilities continue to improve, there is a growing need for protein sequencing technologies to support clinical diagnostics,disease research, and drug discovery.
The increasing burden of chronic and infectious diseases in these regions is driving the demand for accurate molecular tools that provide insights at the protein level. Protein sequencing plays a critical role in identifying biomarkers, understanding pathogen-host interactions, and facilitating the development of targeted therapeutics. This aligns with national health priorities focused on early detection, personalized treatment strategies, and preventive healthcare, making protein sequencing an essential tool in emerging healthcare ecosystems.
At the same time, there is a surge in activity from academic institutions, biotech startups, and R&D centers in these countries. Backed by improved access to funding and growing engagement with global research networks, these organizations are integrating proteomics and protein sequencing technologies into a variety of applications—from vaccine development to agricultural biotechnology. The growing demand for affordable, high-throughput solutions is encouraging greater adoption of advanced protein analysis platforms across multiple sectors.
As awareness and technological capacity expand, emerging economies are set to become major contributors to the future of the protein sequencing industry. Companies that focus on building localized support systems, offering region-specific solutions, and investing in training programs are likely to secure a strong foothold in these high-potential markets. With their large population bases and increasingly sophisticated life sciences sectors, these regions are expected to drive long-term, inclusive growth for the protein sequencing market.
Protein Sequencing Market Competitive Landscape Analysis
Protein Sequencing Market is witnessing heightened competition as leading players refine their strategies to strengthen portfolios and address growing research needs. Increased partnerships and merger initiatives are shaping a dynamic space, where specialized providers and established biotechnology firms aim to secure greater market share through advanced analytical solutions and enhanced customer reach.
Market Structure and Concentration
The industry exhibits a moderately high level of concentration with a few influential companies driving innovation while emerging players seek niche positions. Intense competition fosters diversification of service offerings, and shifting alliances encourage scalable growth models. Strategic acquisitions and technology licensing further redefine value chains, influencing competitive balance and market expansion.
Brand and Channel Strategies
Strong emphasis is placed on differentiated branding and agile distribution strategies to reach varied research segments. Firms invest in robust digital networks and direct collaborations with pharmaceutical and academic sectors to maximize partnerships. Enhanced visibility in specialized sequencing platforms and tailored marketing approaches boost recognition, ensuring consistent customer engagement and long-term positioning.
Innovation Drivers and Technological Advancements
Cutting-edge technological advancements accelerate competitive progress, including automated sequencing workflows and high-throughput systems improving efficiency by notable percentages. Continuous innovation in data analysis tools and reagent quality reinforces competitive differentiation. Strategic R&D investments and collaboration with technology providers support faster product development, sustaining leadership in emerging bioinformatics-driven applications.
Regional Momentum and Expansion
Key regions are experiencing strong expansion as players tap into specialized life science hubs and invest in local infrastructure. Regional partnerships and academic-industry collaborations enhance access to high-demand markets. Increasing adoption in research centers, combined with proactive growth strategies and localized technical support, fortifies competitive standing across advanced and emerging geographies.
Future Outlook
Sustained growth is anticipated as market participants focus on strategic partnerships, targeted acquisitions, and expanded sequencing platforms. Evolving analytical capabilities and technological advancements will drive adoption, while tailored service models increase accessibility. Companies aligning innovative solutions with specialized research demand are positioned to strengthen their long-term competitive edge and market presence.
Key players in Protein Sequencing Market include:
- Thermo Fisher Scientific
- Agilent Technologies
- Shimadzu Corporation
- Bruker Corporation
- Waters Corporation
- Bio-Rad Laboratories
- Charles River Laboratories
- Rapid Novor
- Selvita
- Encodia
- Proteome Factory
- SGS
- Bioinformatics Solutions
- Creative Proteomics
- Danaher Corporation
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product and Service
- Market Snapshot, By Technology
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Protein Sequencing Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Advancements in Proteomics Research
- Growing Demand for Personalized Medicine
- Expanding Applications in Drug Discovery
- Restraints
- High Costs of Sequencing Technologies
- Complex Data Analysis
- Regulatory Compliance Challenges
- Opportunities
- Innovation in next-generation sequencing techniques
- Expansion into clinical diagnostics and biomarkers
- Growing collaborations in pharmaceutical research
- Emerging markets adopting protein analysis tools
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Protein Sequencing Market, By Product and Service, 2021 - 2031 (USD Million)
- Sample Preparation Products & Services
- Protein Sequencing Products
- Reagents & Consumables
- Instruments
- Mass Spectrometry Instruments
- Edman Degradation Sequencers
- Analysis Products & Software
- Protein Sequencing Services
- Others
- Protein Sequencing Market, By Technology, 2021 - 2031 (USD Million)
- Edman Degradation
- Mass Spectrometry
- Protein Sequencing Market, By Application, 2021 - 2031 (USD Million)
- Biotherapeutics
- Genetic Engineering
- Others
- Protein Sequencing Market, By End User, 2021 - 2031 (USD Million)
- Academic Institutes & Research Centers
- Pharmaceutical & Biotechnology Companies
- Others
- Protein Sequencing Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Protein Sequencing Market, By Product and Service, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Thermo Fisher Scientific
- Agilent Technologies
- Shimadzu Corporation
- Bruker Corporation
- Waters Corporation
- Bio-Rad Laboratories
- Charles River Laboratories
- Rapid Novor
- Selvita
- Encodia
- Proteome Factory
- SGS
- Bioinformatics Solutions
- Creative Proteomics
- Danaher Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market